91 Followers on Owler

Galapagos

is a Belgium-based biotechnology company that discovers, develops and commercializes small molecule medicines to the treatment of inflammatory and fibrotic diseases... Read more
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Galapagos

is a Belgium-based biotechnology company that discovers, develops and commercializes small molecule medicines to the treatment of inflammatory and fibrotic diseases... Read more
Galapagos CEO: Henry Gosebruch

CEO

Henry Gosebruch

CEO Approval Rating

82/100

1999

PublicOtherGLPG

Pharmaceuticals & Biotechnology
Biotechnology
28342836 NAICS listing

Annual Revenue
$305.1M
Employees
704
Funding
$282.8M
Acquisitions
5
Investments
3

News

Leadership Change
Feb 20, 2026
GlobalNewswire
Paulo Fontoura joined Galapagos as Non-Executive Independent Director

Galapagos Competitors

1GVK BIO
2Idorsia
3OMass
4PPD
5TCG Lifesciences
6Rhizen
7Evotec
8Syngene
9Clinuvel
10BioPharmaSpec
Unlock 31 + competitors

Trending Companies